Baillie Gifford & Co - Dec 31, 2024 SCHEDULE 13G/A Report for Adaptimmune Therapeutics PLC Common Stock (ADAP)

Filing Manager: BAILLIE GIFFORD & CO
Reporting Manager: BAILLIE GIFFORD & CO
Security: Adaptimmune Therapeutics PLC Common Stock
Symbol: ADAP
Shares outstanding: 1.54B shares
Disclosed Ownership: 70.9M shares
Ownership: 4.6%
Form type: SCHEDULE 13G/A
Date filed: 2/12/2025, 10:25 AM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BAILLIE GIFFORD & CO	4.6%	70.9M	70.9M		Grant Meikle	Threshold & Transaction Reporting Manager